Literature DB >> 21673557

Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing.

Stéphanie Raymond1, Adrien Saliou, Florence Nicot, Pierre Delobel, Martine Dubois, Michelle Cazabat, Karine Sandres-Sauné, Bruno Marchou, Patrice Massip, Jacques Izopet.   

Abstract

We used ultra-deep pyrosequencing and the Toulouse Tropism Test phenotypic assay to determine the prevalence of CXCR4-using viruses in 21 patients with primary HIV-1 infections. We found X4-containing virus populations in 9% of patients by ultra-deep pyrosequencing using position-specific scoring matrices (PSSM(X4/R5)) or geno2pheno(5.75) and in 14% using the combined 11/25 and net charge rule. The phenotypic assay identified 9% of CXCR4-using viruses. This confirms that R5 viruses are predominant in primary HIV-1 infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21673557     DOI: 10.1097/QAD.0b013e3283498305

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  16 in total

1.  Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.

Authors:  Shuntai Zhou; Maria M Bednar; Christa B Sturdevant; Blake M Hauser; Ronald Swanstrom
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

2.  Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?

Authors:  Richard M Gibson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

3.  Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.

Authors:  Doris G Ransy; Alena Motorina; Natacha Merindol; Bertine S Akouamba; Johanne Samson; Yolanda Lie; Laura A Napolitano; Normand Lapointe; Marc Boucher; Hugo Soudeyns
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

4.  Clinical implications of HIV-1 minority variants.

Authors:  Jonathan Z Li; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

Review 5.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

6.  Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.

Authors:  Luke C Swenson; Celia K S Chui; Chanson J Brumme; Dennison Chan; Conan K Woods; Theresa Mo; Winnie Dong; Doug Chapman; Marilyn Lewis; James F Demarest; Ian James; Simon Portsmouth; James Goodrich; Jayvant Heera; Hernan Valdez; P Richard Harrigan
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

7.  Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.

Authors:  John Archer; Jan Weber; Kenneth Henry; Dane Winner; Richard Gibson; Lawrence Lee; Ellen Paxinos; Eric J Arts; David L Robertson; Larry Mimms; Miguel E Quiñones-Mateu
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

8.  Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data.

Authors:  Niko Beerenwinkel; Huldrych F Günthard; Volker Roth; Karin J Metzner
Journal:  Front Microbiol       Date:  2012-09-11       Impact factor: 5.640

9.  Compartmentalization and Clonal Amplification of HIV-1 in the Male Genital Tract Characterized Using Next-Generation Sequencing.

Authors:  Samuel Mundia Kariuki; Philippe Selhorst; Colin Anthony; David Matten; Melissa-Rose Abrahams; Darren P Martin; Kevin K Ariën; Kevin Rebe; Carolyn Williamson; Jeffrey R Dorfman
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

10.  Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.

Authors:  Richard M Gibson; Ashley M Meyer; Dane Winner; John Archer; Felix Feyertag; Ezequiel Ruiz-Mateos; Manuel Leal; David L Robertson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.